Pharmacodynamics and pharmacokinetics of YM128, a GPIIb/IIIa antagonist prodrug-Reference-Cited by-同舟云学术

Pharmacodynamics and pharmacokinetics of YM128, a GPIIb/IIIa antagonist prodrug

Published:2002-03 Issue:3 Volume:55 Page:149-161
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Suzuki Ken-ichi,Moritani Yumiko,Hisamichi Nami,Ichihara Masato,Akamatsu Seijiro,Arai Hiroshi,Matsushima Hiroshi,Nii Tomoko,Sato Kazuo,Taniuchi Yuta,Shigenaga Takeshi,Kaku Seiji,Kawasaki Tomihisa,Matsumoto Yuzo,Inagaki Osamu,Tomioka Kenichi,Yanagisawa Isao

Publisher

Wiley

Subject

Drug Discovery

Reference28 articles.

1. Interspecies Comparison of the Antiplatelet, Antithrombotic, and Hemorrhagic Effects of SR 121566A, a Novel Nonpeptide GP IIb/IIIa Antagonist

2. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study

3. Platelet glycoproteins IIb and IIIa: evidence for a family of immunologically and structurally related glycoproteins in mammalian cells.

4. The Effects of Two Synthetic Glycoprotein II b/III a Antagonists, Ro 43-8857 and L-700,462, on Platelet Aggregation and Bleeding in Guinea-Pigs and Dogs: Evidence that Ro 43-8857 Is Orally Active

5. Pentamidine: A Non-Peptide GPIIb/IIIa Antagonist – In Vitro Studies on Platelets from Humans and Other Species

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel anti-platelet peptide (Z4A5) potential for glycoprotein IIb/IIIa inhibits platelet aggregation;Thrombosis Research;2012-05

2. Investigation on pharmacokinetics, tissue distribution and excretion of a novel anticancer platinum compound by inductively coupled plasma mass spectrometry after intravenous administration to rats;Archives of Pharmacal Research;2009-11

3. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice;Thrombosis and Haemostasis;2004